Response Rates and Transplantation Impact in Patients with Relapsed Acute Promyelocytic Leukemia
Our findings support the efficacy of ATO-based therapies in first relapse of APL and confirm the achievement of molecular remission as an independent outcome predictor in both first and second APL relapse.
Authors
- Luca Guarnera (ORCID: https://orcid.org/0000-0001-8293-0663)
- Laura Cicconi (ORCID: https://orcid.org/0000-0001-5642-3051)
- Maurizio Martelli (ORCID: https://orcid.org/0000-0003-1007-0339)
- Clara Minotti
- Raffaella Cerretti (ORCID: https://orcid.org/0000-0003-3638-0650)
- Emilia Scalzulli
- Alessandro Nanni Costa (ORCID: https://orcid.org/0000-0002-7726-2936)
- Carmelo Gurnari (ORCID: https://orcid.org/0000-0001-6829-5544)
- Ida Carmosino
- Maria Teresa Voso (ORCID: https://orcid.org/0000-0002-6164-4761)
- Maria Laura Bisegna
- Anna Paola Iori (ORCID: https://orcid.org/0000-0002-1216-5270)
- Lorenzo Torrieri
- Alessandro Pulsoni (ORCID: https://orcid.org/0000-0001-7429-8004)
- Massimo Breccia (ORCID: https://orcid.org/0000-0003-1163-6162)
- Saveria Capria (ORCID: https://orcid.org/0000-0002-3064-9332)
- Adriano Venditti (ORCID: https://orcid.org/0000-0002-0245-0553)
Institutions
- University of Rome Tor Vergata (IT)
- University of Cagliari (IT)
- Policlinico Umberto I (IT)
- Ospedale Santa Maria Goretti (IT)
Publication Details
- Journal
- Cancers
- Published
- 2024-09-21
- DOI
- https://doi.org/10.3390/cancers16183214
- Citations
- 3
- Primary Topic
- Retinoids in leukemia and cellular processes
- Type
- article
- Field-Weighted Citation Impact
- 0.70